AU2003284678B2 - Interleukin 6 production inhibitor - Google Patents

Interleukin 6 production inhibitor Download PDF

Info

Publication number
AU2003284678B2
AU2003284678B2 AU2003284678A AU2003284678A AU2003284678B2 AU 2003284678 B2 AU2003284678 B2 AU 2003284678B2 AU 2003284678 A AU2003284678 A AU 2003284678A AU 2003284678 A AU2003284678 A AU 2003284678A AU 2003284678 B2 AU2003284678 B2 AU 2003284678B2
Authority
AU
Australia
Prior art keywords
leu
pro
arg
asn
lys
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU2003284678A
Other languages
English (en)
Other versions
AU2003284678A1 (en
Inventor
Masahiko Kurokawa
Kouichirou Shin
Kimiyasu Shiraki
Yoshitaka Tamura
Hiroyuki Wakabayashi
Koji Yamauchi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Morinaga Milk Industry Co Ltd
Original Assignee
Morinaga Milk Industry Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Morinaga Milk Industry Co Ltd filed Critical Morinaga Milk Industry Co Ltd
Publication of AU2003284678A1 publication Critical patent/AU2003284678A1/en
Application granted granted Critical
Publication of AU2003284678B2 publication Critical patent/AU2003284678B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y111/00—Oxidoreductases acting on a peroxide as acceptor (1.11)
    • C12Y111/01—Peroxidases (1.11.1)
    • C12Y111/01007—Peroxidase (1.11.1.7), i.e. horseradish-peroxidase
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/44—Oxidoreductases (1)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Urology & Nephrology (AREA)
  • Biochemistry (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Zoology (AREA)
  • Rheumatology (AREA)
  • Mycology (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • General Engineering & Computer Science (AREA)
  • Vascular Medicine (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Molecular Biology (AREA)
  • Pain & Pain Management (AREA)
AU2003284678A 2003-02-24 2003-11-25 Interleukin 6 production inhibitor Ceased AU2003284678B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2003-45509 2003-02-24
JP2003045509 2003-02-24
PCT/JP2003/015009 WO2004073733A1 (ja) 2003-02-24 2003-11-25 インターロイキン−６産生抑制剤

Publications (2)

Publication Number Publication Date
AU2003284678A1 AU2003284678A1 (en) 2004-09-09
AU2003284678B2 true AU2003284678B2 (en) 2006-02-23

Family

ID=32905527

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003284678A Ceased AU2003284678B2 (en) 2003-02-24 2003-11-25 Interleukin 6 production inhibitor

Country Status (9)

Country Link
US (2) US7282202B2 (de)
EP (1) EP1598076A4 (de)
JP (1) JP3738268B2 (de)
KR (1) KR100688928B1 (de)
CN (1) CN1311870C (de)
AU (1) AU2003284678B2 (de)
CA (1) CA2489208C (de)
NZ (1) NZ537089A (de)
WO (1) WO2004073733A1 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100688928B1 (ko) * 2003-02-24 2007-03-02 모리나가 뉴교 가부시키가이샤 인터류킨-6 생성 억제제
CN101360508B (zh) 2006-01-20 2012-09-05 森永乳业株式会社 用于肠道疾病的药物组合物、饮食品或饲料
JP2007223910A (ja) * 2006-02-21 2007-09-06 Snow Brand Milk Prod Co Ltd 抗炎症剤
KR100736159B1 (ko) * 2006-06-29 2007-07-06 주식회사 알앤엘바이오 상사화 추출물을 함유하는 항바이러스 조성물
KR100721703B1 (ko) * 2006-06-29 2007-05-25 주식회사 알앤엘바이오 오리나무 추출물을 함유하는 항바이러스 조성물
JP2008189637A (ja) * 2007-02-08 2008-08-21 Snow Brand Milk Prod Co Ltd 自己免疫疾患予防剤

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
LU85479A1 (fr) 1984-07-25 1986-02-12 Oleofina Sa Compositions antibacteriennes de nourriture pour animaux et procede pour les preparer
US6020015A (en) 1988-09-22 2000-02-01 Gaull; Gerald E. Infant formula compositions and nutrition containing genetically engineered human milk proteins
DE3834636A1 (de) 1988-10-11 1990-04-19 Max Planck Gesellschaft Verfahren zur analyse von laengenpolymorphismen in dna-bereichen
JPH03218318A (ja) 1989-11-02 1991-09-25 Chugai Pharmaceut Co Ltd ロタウイルス感染症治療剤の製法
CA2067334C (en) * 1989-11-03 2001-02-13 Jeffrey J. Seilhamer Recombinant production of lactoperoxidase
GB9015910D0 (en) 1990-07-19 1990-09-05 Univ Bruxelles Novel use
WO1992008477A1 (en) * 1990-11-13 1992-05-29 Santen Pharmaceutical Co., Ltd. Therapeutic agent for corneal lesion
JP3103615B2 (ja) 1991-05-13 2000-10-30 株式会社イムノ・ジャパン 養殖水生動物の配合飼料に添加される病原菌感染予防及び治療剤
JP3510639B2 (ja) * 1991-06-28 2004-03-29 カルピス株式会社 インターロイキン産生能を調節する機能を持たせた機能性食品又は健康食品
JP3103167B2 (ja) 1991-10-30 2000-10-23 雪印乳業株式会社 老化防止剤
WO1994014467A1 (en) * 1992-12-29 1994-07-07 Genentech, Inc. Treatment of inflammatory bowel disease with ifn-gamma inhibitors
WO1996012503A1 (fr) * 1994-10-21 1996-05-02 Chugai Seiyaku Kabushiki Kaisha Remede contre des maladies provoquees par la production d'il-6
SE506529C2 (sv) 1996-01-23 1997-12-22 Semper Ab Användning av ett laktoperoxidassystem för framställning av ett läkemedel mot Helicobacter pylori
ES2138561B1 (es) 1998-04-17 2000-07-01 Univ Madrid Complutense Uso de los peptidos vip y pacap en el tratamiento del shock endotoxico en mamiferos.
JP4679687B2 (ja) 2000-02-16 2011-04-27 雪印乳業株式会社 肝機能改善剤
JP4382295B2 (ja) 2001-02-15 2009-12-09 森永乳業株式会社 ウレアーゼ不活性化組成物及び飲食品
EP1390497A2 (de) * 2001-05-25 2004-02-25 Genset Menschliche cdns und proteine und verwendungen davon
KR100688928B1 (ko) * 2003-02-24 2007-03-02 모리나가 뉴교 가부시키가이샤 인터류킨-6 생성 억제제

Also Published As

Publication number Publication date
US7282202B2 (en) 2007-10-16
NZ537089A (en) 2007-07-27
EP1598076A4 (de) 2008-07-09
KR20050044774A (ko) 2005-05-12
WO2004073733A1 (ja) 2004-09-02
KR100688928B1 (ko) 2007-03-02
CA2489208C (en) 2012-11-06
US20080160005A1 (en) 2008-07-03
EP1598076A1 (de) 2005-11-23
US20050249715A1 (en) 2005-11-10
CN1691959A (zh) 2005-11-02
US7731955B2 (en) 2010-06-08
JPWO2004073733A1 (ja) 2006-06-01
AU2003284678A1 (en) 2004-09-09
JP3738268B2 (ja) 2006-01-25
CN1311870C (zh) 2007-04-25
CA2489208A1 (en) 2004-09-02

Similar Documents

Publication Publication Date Title
US7731955B2 (en) Interleukin-6 suppressive agent
US20120322726A1 (en) Therapeutic agent for eating disorders
US20110262421A1 (en) Pharmaceutical composition, food or drink, or feed for intestinal disease
EP2668851B1 (de) Leberfunktion verbesserndes Mittel
CN116590200A (zh) 约氏乳杆菌及其在制备预防和/或改善急性胰腺炎的产品中的应用
CN116847854A (zh) 包含岩藻糖基乳糖作为有效成分的抗病毒组合物
JP5504441B2 (ja) ミトコンドリア融合促進剤
KR102143608B1 (ko) 락토바실러스 사케이 k040706을 함유하는 바이러스 감염 질환 예방 또는 치료용 조성물
JP4868700B2 (ja) プロテアーゼ阻害剤
JP2004083487A (ja) 抗ウイルス組成物及びウイルス感染症予防・治療用組成物
KR102619071B1 (ko) 돼지 g-csf 변이체 및 그 용도
TWI828126B (zh) 用以治療高三酸甘油脂血症或其相關疾病的方法
JP2009263255A (ja) 新規ペプチド
Singh et al. Antiviral properties of milk proteins and peptides against SARS-COV-2: A review
WO2006095433A1 (ja) ウシの消化器疾患治療剤
JP2005089301A (ja) ウシの消化器疾患治療剤
JP2004256395A (ja) 白血球遊走能調節剤
TW202402190A (zh) 包含源自乳清蛋白的肽的生長促進用組合物
KR20200033685A (ko) 해동피 추출물을 유효성분으로 포함하는 면역력 증진용 조성물
JP2009137982A (ja) インターロイキン−１８誘導剤

Legal Events

Date Code Title Description
DA3 Amendments made section 104

Free format text: THE NATURE OF THE AMENDMENT IS: AMEND THE NAME OF THE CO-INVENTOR TO READ YAMAUCHI, KOJI

FGA Letters patent sealed or granted (standard patent)
MK14 Patent ceased section 143(a) (annual fees not paid) or expired